Tagrisso approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer Read more
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA (voxelotor) From Worldwide Markets Read more
Lilly’s Kisunla (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer’s Disease Read more
Papillon Therapeutics Secures Orphan Drug Designation from FDA for PPL-001 in Friedreich’s Ataxia Treatment Read more
FDA Approves Merck’s KEYTRUDA (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM) Read more
BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy Read more
Cell Therapy Analytical and Quality Control Experts to Gather in Boston this December for the 6th Cell Therapy Analytical Development Summit Read more
Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ, to EMA and Health Canada Read more